Search
SF Healthcare Week: Flagship Pioneering's Founder Noubar Afeyan shares his thoughts on the image of science in the United States today, biotech's roller coaster 2025, mRNA, AI, and more
He discusses the theme of his annual letter that was published today, "Choosing Science," and why it is important that our country continues to invest in basic research. Plus, his take on the M&A environment in biotech.
Jan 12
SF Healthcare Week: Flagship Pioneering's Noubar Afeyan on Moderna, gov't policy, China, and "polyintelligence" in drug development
He shares his thoughts on Moderna's transition, what policies he would like to see promoted in government, competing with China, and the...
Jan 13, 2025
Flagship Pioneering's founder & CEO Noubar Afeyan discusses his firm's $3.6B fundraise today
Noubar Afeyan describes some areas that he sees the funding being deployed, his take on the current state of biotech, the IPO market,...
Jul 10, 2024
Flagship Pioneering's Noubar Afeyan's take on biotech heading into 2024
Noubar Afeyan hits on themes like partnering with pharma in earlier stages, AI, and the globalization of biotech.
Jan 8, 2024
Noubar Afeyan discusses the year ahead
Flagship Pioneering’s Noubar Afeyan gives his take on the biotech sector for the year ahead at #JPM23.
Jan 9, 2023
Noubar Afeyan on Moderna and Biotech Innovation
Flagship Pioneering's Noubar Afeyan describes what it was like to navigate the pandemic as Chairman of Moderna.
Jun 22, 2022
.png){kind=logo}
